153 related articles for article (PubMed ID: 30365931)
1. Immunoglobulin E-Selective Immunoadsorption Reduces Peripheral and Skin-Bound Immunoglobulin E and Modulates Cutaneous IL-13 Expression in Severe Atopic Dermatitis.
Reich K; Hartjen A; Reich J; Schröder J; Steingrube N; Bresch M; Ertas B; Falk TM; Blödorn-Schlicht N; Jäckle S; Meier M
J Invest Dermatol; 2019 Mar; 139(3):720-723. PubMed ID: 30365931
[No Abstract] [Full Text] [Related]
2. IgE-specific immunoadsorption: New treatment option for severe refractory atopic dermatitis.
Wegner J; Saloga J; Grabbe S; Wilden S; Vewinger N; Lutz J; Weinmann-Menke J; von Stebut E
Allergy; 2019 Jun; 74(6):1190-1193. PubMed ID: 30636038
[No Abstract] [Full Text] [Related]
3. Improvement of treatment-refractory atopic dermatitis by immunoadsorption: a pilot study.
Kasperkiewicz M; Schmidt E; Frambach Y; Rose C; Meier M; Nitschke M; Falk TM; Reich K; Ludwig RJ; Zillikens D
J Allergy Clin Immunol; 2011 Jan; 127(1):267-70, 270.e1-6. PubMed ID: 20970174
[No Abstract] [Full Text] [Related]
4. Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis.
Reich K; Deinzer J; Fiege AK; von Gruben V; Sack AL; Thraen A; Weisenseel P; Breuer K; Jäckle S; Meier M
J Allergy Clin Immunol; 2016 Jun; 137(6):1882-1884.e6. PubMed ID: 26993034
[No Abstract] [Full Text] [Related]
5. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis.
Akdis CA; Akdis M; Simon D; Dibbert B; Weber M; Gratzl S; Kreyden O; Disch R; Wüthrich B; Blaser K; Simon HU
J Invest Dermatol; 1999 Oct; 113(4):628-34. PubMed ID: 10504452
[TBL] [Abstract][Full Text] [Related]
6. IL-13 over-expression in skin is not confined to IgE-mediated skin inflammation.
Van der Ploeg I; Jeddi Tehrani M; Matuseviciene G; Wahlgren CF; Fransson J; Scheynius A
Clin Exp Immunol; 1997 Sep; 109(3):526-32. PubMed ID: 9328132
[TBL] [Abstract][Full Text] [Related]
7. IgE-specific immunoadsorption for treatment of recalcitrant atopic dermatitis.
Kasperkiewicz M; Süfke S; Schmidt E; Zillikens D
JAMA Dermatol; 2014 Dec; 150(12):1350-1. PubMed ID: 25271706
[No Abstract] [Full Text] [Related]
8. Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis.
Kasperkiewicz M; Schmidt E; Ludwig RJ; Zillikens D
Front Immunol; 2018; 9():254. PubMed ID: 29520268
[TBL] [Abstract][Full Text] [Related]
9. T cells and mast cells as a major source of interleukin-13 in atopic dermatitis.
Obara W; Kawa Y; Ra C; Nishioka K; Soma Y; Mizoguchi M
Dermatology; 2002; 205(1):11-7. PubMed ID: 12145428
[TBL] [Abstract][Full Text] [Related]
10. Anaphylaxis to oats after cutaneous sensitization by oatmeal in skin products used for the treatment of atopic dermatitis.
Radhakrishna N; Prickett S; Phan T; Rolland JM; Puy R; O'Hehir RE
J Allergy Clin Immunol Pract; 2016; 4(1):152-3. PubMed ID: 26282159
[No Abstract] [Full Text] [Related]
11. Pilot investigation of a model for canine atopic dermatitis: environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs.
Marsella R; Olivry T; Nicklin C; Lopez J
Vet Dermatol; 2006 Feb; 17(1):24-35. PubMed ID: 16412117
[TBL] [Abstract][Full Text] [Related]
12. Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and Omalizumab.
Zink A; Gensbaur A; Zirbs M; Seifert F; Suarez IL; Mourantchanian V; Weidinger S; Mempel M; Ring J; Ollert M
Acta Derm Venereol; 2016 Jan; 96(1):72-6. PubMed ID: 26059424
[TBL] [Abstract][Full Text] [Related]
13. Localization of interleukin-13 gene-expressing cells in tuberculin reactions and lesional skin from patients with atopic dermatitis.
van der Ploeg I; Matuseviciene G; Fransson J; Wahlgren CF; Olsson T; Scheynius A
Scand J Immunol; 1999 Apr; 49(4):447-53. PubMed ID: 10219773
[TBL] [Abstract][Full Text] [Related]
14. Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA- memory T cells.
Akdis M; Akdis CA; Weigl L; Disch R; Blaser K
J Immunol; 1997 Nov; 159(9):4611-9. PubMed ID: 9379063
[TBL] [Abstract][Full Text] [Related]
15. Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis.
Tazawa T; Sugiura H; Sugiura Y; Uehara M
Arch Dermatol Res; 2004 Apr; 295(11):459-64. PubMed ID: 15014952
[TBL] [Abstract][Full Text] [Related]
16. [Etiology and treatment of atopic dermatitis in the light of new data].
Gendek H
Pol Tyg Lek; 1981 Sep; 36(37):1447-50. PubMed ID: 6278456
[No Abstract] [Full Text] [Related]
17. Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome.
Ruzicka T; Glück S
Arch Dermatol Res; 1983; 275(1):41-4. PubMed ID: 6189456
[TBL] [Abstract][Full Text] [Related]
18. rBlo t 5 is a potential contributor to the severity of atopic dermatitis in a Brazilian population.
Camargo Lopes de Oliveira L; Pierotti FF; Mallozi M; Rodrigues Cocco R; Rosário N; Rugue Genov I; Åberg KM; Borres MP; Solé D
Pediatr Allergy Immunol; 2019 Aug; 30(5):575-579. PubMed ID: 30838693
[No Abstract] [Full Text] [Related]
19. IL-13 gene expression in patients with atopic dermatitis: relation to IgE level and to disease severity.
Metwally SS; Mosaad YM; Abdel-Samee ER; El-Gayyar MA; Abdel-Aziz AM; El-Chennawi FA
Egypt J Immunol; 2004; 11(2):171-7. PubMed ID: 16734130
[TBL] [Abstract][Full Text] [Related]
20. Differential gene expression for interleukin-13 and other cytokines in the skin of atopic dermatitis patients and healthy subjects.
Van der Ploeg I; Tengvall Linder M; Hägermark O; Wahlgren CF; Scheynius A
Adv Exp Med Biol; 1996; 409():403-4. PubMed ID: 9095273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
